Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-19 9:31 pm Sale | 13D | Tyra Biosciences Inc. TYRA | Boxer Capital Management LLC | 4,071,854 7.700% | -914,461 (-18.34%) | View |
| 2024-11-14 5:47 pm Purchase | 13G | Tyra Biosciences Inc. TYRA | NEXTECH VI ONCOLOGY SCSP | 4,055,861 7.700% | 1,537,279 (+61.04%) | View |
| 2024-11-14 4:34 pm Purchase | 13G | Tyra Biosciences Inc. TYRA | BIOTECHNOLOGY VALUE FUND L P | 4,661,194 8.800% | 1,921,599 (+70.14%) | View |
| 2024-11-13 6:04 pm Purchase | 13D | Tyra Biosciences Inc. TYRA | RA CAPITAL MANAGEMENT L.P. | 10,677,140 21.100% | 586,069 (+5.81%) | View |
| 2024-11-12 10:34 am Sale | 13G | Tyra Biosciences Inc. TYRA | FMR LLC | 3,372,850 6.387% | -1,281,426 (-27.53%) | View |
| 2024-10-22 9:15 pm Purchase | 13D | Tyra Biosciences Inc. TYRA | Boxer Capital Management LLC | 4,986,315 9.900% | 4,986,315 (New Position) | View |
| 2024-10-22 5:11 pm Sale | 13D | Tyra Biosciences Inc. TYRA | RA CAPITAL MANAGEMENT L.P. | 10,091,071 19.990% | -384,418 (-3.67%) | View |
| 2024-10-15 9:59 pm Purchase | 13D | Tyra Biosciences Inc. TYRA | Boxer Capital LLC | 6,534,298 12.400% | 85,939 (+1.33%) | View |
| 2024-10-15 7:22 pm Unchanged | 13D | Tyra Biosciences Inc. TYRA | Boxer Asset Management Inc. | 0 0.000% | 0 (Unchanged) | View |
| 2024-03-11 08:19 am Purchase | 13G | Tyra Biosciences Inc. TYRA | FMR LLC | 4,654,276 10.809% | 1,885,580 (+68.10%) | View |
| 2024-02-14 09:24 am Purchase | 13G | Tyra Biosciences Inc. TYRA | BIOTECHNOLOGY VALUE FUND L P | 2,739,595 6.400% | 267,268 (+10.81%) | View |
| 2024-02-09 10:05 am Sale | 13G | Tyra Biosciences Inc. TYRA | FMR LLC | 2,768,696 6.430% | -1,110,427 (-28.63%) | View |
| 2024-02-08 5:10 pm Purchase | 13D | Tyra Biosciences Inc. TYRA | Boxer Capital LLC | 6,448,359 12.300% | 125,000 (+1.98%) | View |
| 2024-02-06 4:40 pm Purchase | 13D | Tyra Biosciences Inc. TYRA | RA CAPITAL MANAGEMENT L.P. | 10,475,489 19.990% | 3,239,035 (+44.76%) | View |
| 2023-02-09 12:39 pm Purchase | 13G | Tyra Biosciences Inc. TYRA | FMR LLC | 3,879,123 9.192% | 410,292 (+11.83%) | View |
| 2022-06-15 7:11 pm Unchanged | 13D | Tyra Biosciences Inc. TYRA | Boxer Capital LLC | 6,323,359 15.100% | 0 (Unchanged) | View |
| 2022-03-24 4:22 pm Purchase | 13G | Tyra Biosciences Inc. TYRA | BIOTECHNOLOGY VALUE FUND L P | 2,472,327 5.900% | 2,472,327 (New Position) | View |
| 2022-02-09 10:01 am Purchase | 13G | Tyra Biosciences Inc. TYRA | FMR LLC | 3,468,831 8.406% | 3,468,831 (New Position) | View |
| 2022-02-08 3:28 pm Purchase | 13G | Tyra Biosciences Inc. TYRA | Canaan XI L.P. | 3,936,595 9.500% | 3,936,595 (New Position) | View |
| 2021-09-29 06:01 am Unchanged | 13G | Tyra Biosciences Inc. TYRA | TCG Crossover Management LLC | 937,500 2.200% | 0 (Unchanged) | View |